HCWB Annual EBITDA
-$23.58 M
-$9.52 M-67.73%
31 December 2023
Summary:
As of January 21, 2025, HCWB annual earnings before interest, taxes, depreciation & amortization is -$23.58 million, with the most recent change of -$9.52 million (-67.73%) on December 31, 2023. During the last 3 years, it has fallen by -$18.32 million (-348.92%). HCWB annual EBITDA is now -348.92% below its all-time high of -$5.25 million, reached on December 31, 2020.HCWB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HCWB Quarterly EBITDA
-$3.55 M
+$11.44 M+76.32%
30 September 2024
Summary:
As of January 21, 2025, HCWB quarterly earnings before interest, taxes, depreciation & amortization is -$3.55 million, with the most recent change of +$11.44 million (+76.32%) on September 30, 2024. Over the past year, it has increased by +$1.02 million (+22.24%). HCWB quarterly EBITDA is now -261.25% below its all-time high of $2.20 million, reached on December 31, 2020.HCWB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HCWB TTM EBITDA
-$36.17 M
+$1.02 M+2.73%
30 September 2024
Summary:
As of January 21, 2025, HCWB TTM earnings before interest, taxes, depreciation & amortization is -$36.17 million, with the most recent change of +$1.02 million (+2.73%) on September 30, 2024. Over the past year, it has dropped by -$17.94 million (-98.41%). HCWB TTM EBITDA is now -1508.34% below its all-time high of -$2.25 million, reached on March 31, 2020.HCWB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HCWB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.7% | +22.2% | -98.4% |
| 3 y3 years | -348.9% | +22.2% | -98.4% |
| 5 y5 years | -239.5% | +22.2% | -98.4% |
HCWB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.4% | at low | -85.5% | +76.3% | -229.4% | +2.7% |
| 5 y | 5-year | -348.9% | at low | -261.3% | +76.3% | -1508.3% | +2.7% |
| alltime | all time | -348.9% | at low | -261.3% | +76.3% | -1508.3% | +2.7% |
HCW Biologics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.55 M(-76.3%) | -$36.17 M(-2.7%) |
| June 2024 | - | -$14.99 M(+107.5%) | -$37.19 M(+42.4%) |
| Mar 2024 | - | -$7.22 M(-30.6%) | -$26.12 M(+10.8%) |
| Dec 2023 | -$23.58 M(+67.7%) | -$10.41 M(+127.9%) | -$23.58 M(+29.3%) |
| Sept 2023 | - | -$4.57 M(+16.3%) | -$18.23 M(+4.9%) |
| June 2023 | - | -$3.92 M(-16.1%) | -$17.38 M(+3.4%) |
| Mar 2023 | - | -$4.68 M(-7.6%) | -$16.82 M(+19.7%) |
| Dec 2022 | -$14.06 M | -$5.06 M(+36.2%) | -$14.06 M(+22.3%) |
| Sept 2022 | - | -$3.72 M(+10.6%) | -$11.49 M(-2.1%) |
| June 2022 | - | -$3.36 M(+75.6%) | -$11.74 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$1.91 M(-23.4%) | -$10.98 M(-10.9%) |
| Dec 2021 | -$12.32 M(+134.6%) | -$2.50 M(-37.0%) | -$12.32 M(+61.7%) |
| Sept 2021 | - | -$3.97 M(+52.9%) | -$7.62 M(+22.3%) |
| June 2021 | - | -$2.60 M(-20.2%) | -$6.23 M(-0.4%) |
| Mar 2021 | - | -$3.25 M(-247.8%) | -$6.26 M(+19.1%) |
| Dec 2020 | -$5.25 M(-24.4%) | $2.20 M(-185.3%) | -$5.25 M(-29.5%) |
| Sept 2020 | - | -$2.58 M(-1.5%) | -$7.45 M(+53.0%) |
| June 2020 | - | -$2.62 M(+16.6%) | -$4.87 M(+116.6%) |
| Mar 2020 | - | -$2.25 M | -$2.25 M |
| Dec 2019 | -$6.94 M | - | - |
FAQ
- What is HCW Biologics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for HCW Biologics?
- What is HCW Biologics annual EBITDA year-on-year change?
- What is HCW Biologics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for HCW Biologics?
- What is HCW Biologics quarterly EBITDA year-on-year change?
- What is HCW Biologics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for HCW Biologics?
- What is HCW Biologics TTM EBITDA year-on-year change?
What is HCW Biologics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of HCWB is -$23.58 M
What is the all time high annual EBITDA for HCW Biologics?
HCW Biologics all-time high annual earnings before interest, taxes, depreciation & amortization is -$5.25 M
What is HCW Biologics annual EBITDA year-on-year change?
Over the past year, HCWB annual earnings before interest, taxes, depreciation & amortization has changed by -$9.52 M (-67.73%)
What is HCW Biologics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of HCWB is -$3.55 M
What is the all time high quarterly EBITDA for HCW Biologics?
HCW Biologics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.20 M
What is HCW Biologics quarterly EBITDA year-on-year change?
Over the past year, HCWB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.02 M (+22.24%)
What is HCW Biologics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of HCWB is -$36.17 M
What is the all time high TTM EBITDA for HCW Biologics?
HCW Biologics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.25 M
What is HCW Biologics TTM EBITDA year-on-year change?
Over the past year, HCWB TTM earnings before interest, taxes, depreciation & amortization has changed by -$17.94 M (-98.41%)